Adam Walker’s Pharma Prescribed Podcast

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Steven Thompson is someone who has spent more than two decades reshaping how clinical research actually gets done. He is the Founder of NexTrial.ai, and a leading voice at the intersection of AI, trial activation, and human centred design in healthcare. Across roles at ADM, NuBank, Takeda, and Biogen, Steven built a reputation for transforming complex, slow, legacy processes into streamlined systems that empower the people doing the work. His philosophy is simple but radical: AI shouldn’t replace humans - it should erase the maze that holds them back. At NexTrial.ai, he’s pioneering Trial Activation & Execution Intelligence that delivers zero rejection packets, faster startup, stronger compliance and a future where coordinators, physicians, and teams can operate at their highest capability. Steven brings clarity, courage, and a builder’s mindset to every conversation.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Scott Schliebner is a seasoned biopharmaceutical executive with nearly 30 years of experience spanning biotech, CROs, and nonprofit life sciences organizations. He currently serves as CEO and Founder of Assent Biostrategies. Throughout his career, Scott has built and led high‑impact teams across drug development, commercial strategy, and patient‑centric innovation. His leadership includes senior roles such as Chief Commercial Officer for early‑stage biopharma service organizations and Senior Vice President at TFS HealthScience, where he oversaw clinical development services and contributed to corporate strategy and acquisition due diligence. Scott is widely recognized as a patient advocate and strategic thinker who helps biotech companies accelerate their pipelines and design development programs that meaningfully incorporate patient needs.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Sylvain Berthelot is a clinical technology and life sciences professional with deep expertise in clinical systems and the digital ecosystem that supports modern clinical research. Having worked extensively with sponsors, CROs, and clinical teams, he understands how technology can either streamline or complicate the delivery of high‑quality, compliant clinical trials. In 2024, he joined CRScube, a company whose mission aligns with his commitment to simplifying clinical trial execution through intuitive, people‑centred technology. Alongside his work in clinical innovation, Sylvain is an active voice in industry and patient‑centric conversations through podcasting. He hosts Clinical Data Talks, a podcast that explores the challenges, innovations, and real‑world experiences shaping clinical data management and clinical operations. Sylvain also hosts On One Condition, a human‑focused podcast that raises awareness about chronic health conditions by sharing personal stories. Combining technical expertise with a strong human perspective, Sylvain is dedicated to bridging the gap between systems, data, and the people they ultimately serve.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Jura Lasus is a clinical research leader and biotech consultant specializing in rare disease clinical operations for small biopharma and biotech companies. With over 20 years bridging academia and industry, she’s become the operational compass for biotechs navigating their early phase clinical trials. Her journey began more than 2 decades ago in a newly independent Lithuania, where she stood at an airport with $400 in her pocket and a one-way ticket to America. That calculated risk, leaving everything known for everything possible, became the template for her career: courage mixed with ruthless pragmatism. She holds a PhD in Neurobiology, which shapes how she approaches both science and leadership. Her career spans both CRO and sponsor side leadership, and she has lived and worked across three continents. That global experience gives her a strong understanding of cultural differences in medicine, research, communication, and decision making.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Duncan Kemp is the founder of Saltware Solutions, a software consultancy firm with a mission to empower life science businesses with innovative and reliable solutions that drive efficiency, enhance productivity, and foster growth. With over 20 years leading the development of software for the life sciences industry, Duncan has translated customer requirements to technical concepts with clarity, so incredible ideas are converted into tangible business benefits. His journey began in 1998 during university whilst working at a small startup developing site automation software for phase I trials. Over a period of two decades Duncan navigated several company acquisitions which resulted in leading multiple teams of software engineers across three continents. In January 2024 that all changed when Duncan was restructured out of his role and decided to make the daunting leap into setting up a business. In March 2025 Duncan and I met at the Association of Clinical Data Mgt event in the beautiful city of Prague. We struck up a friendship and after an amusing butt-dial have kept in contact ever since.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Today, I’m joined by Poorya Amini, founder and CEO of Risklick, a Swiss digital health company that’s redefining how clinical trial protocols are designed. Poorya’s journey spans veterinary medicine, a PhD in pharmacology, and hands‑on experience managing cardiology trials at the University of Bern. In 2019, he launched Risklick to tackle one of pharma’s biggest bottlenecks: protocol inefficiency. Risklick’s flagship product, Protocol AI™, draws on a database of over 800,000 clinical trials to cut protocol development time by 50%, reduce amendments by 20%, and shorten implementation by 40%.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Matt Veatch is President and COO of Navidence, and a driving force behind the Real World Wednesdays podcast—a weekly forum that’s reshaping how we think about real-world data (RWD) and real-world evidence (RWE). With more than 25 years of experience advising life sciences organizations, Matt brings a rare blend of operational insight and visionary thinking to the table. He’s a board member of the Decentralized Trials & Research Alliance (DTRA) and is a regular voice at global summits and conferences.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Alan Salter is a professional whose career spans military service, international business and healthcare leadership. A proud U.S. Navy veteran, Alan served with distinction before transitioning into the private sector, where he established a management consulting company Caravel International Partners, a strategic venture based in Chicago. In addition, Alan is also President of NRP (Nonprofit Resource Partners) which supports companies by providing fractional(temp) staffing on a not-for-profit basis. His time in the Navy instilled a deep sense of discipline, resilience, and global perspective—qualities that continue to shape his approach to leadership and governance. Alan’s journey reflects a rare blend of service and strategy. From navigating the rigors of military life to steering entrepreneurial ventures, he brings a grounded yet visionary lens to the evolving role of pharmacy and healthcare delivery.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Dr. Daniel Fox, CEO of CRPN Central is a leader redefining clinical research through decentralised, patient-first platforms. With a background in medicine, policy, and digital innovation, Dr. Fox is building scalable ecosystems that restore trust and transparency in trials. His work bridges the technical and the human, empowering communities to take part in research that reflects their needs and values. CRPN’s network spans thousands of professionals, and its mission is clear: restore trust, streamline operations, and make trials truly inclusive. From platform design to public health advocacy, Dr. Fox brings clarity to complexity and compassion to clinical strategy.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Wendy Turenne, widely known in the industry as “Real World Wendy,” is a strategic force in real-world data and evidence generation. Most recently, she served as Senior Vice President of Real World Data and Delivery Operations at Aetion, where she led global teams in transforming RWD into regulatory-grade evidence for pharma, biotech, and health authorities. Prior to Aetion, Wendy held other pivotal roles at Evolent Health, Alere, and Children’s National Hospital, where she built analytics capabilities, scaled delivery operations, and advanced population health initiatives. Her career spans over 20 years across providers, payers, health tech, and government sectors—giving her a uniquely holistic view of the healthcare data ecosystem. Now an independent consultant, Wendy advises life sciences companies on data maturity, evidence strategy, and operational readiness. Whether guiding regulatory strategy or optimizing delivery models, Wendy continues to be a trusted voice in the evolving landscape of data-driven healthcare.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Dr. Andrée Bates is a pioneering force in pharmaceutical AI, known for transforming how life sciences companies harness data to drive growth, innovation, and patient outcomes. As Founder and CEO of Eularis, Dr. Bates has spent over two decades helping top-tier pharma and biotech firms solve complex commercial challenges using artificial intelligence. With a PhD in Neuroscience and Cognitive Science, and a career that began in medical writing and digital transformation, she’s long been at the forefront of healthcare innovation. Dr. Bates lectures in MBA programs on health innovation and AI, and contributing thought leadership, her work reflecting a rare blend of scientific rigor, commercial insight, and visionary thinking.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Sverre Bengtsson is a trailblazer in clinical trial innovation and digital transformation. As Co Founder at Viedoc Technologies, he has helped shape one of the most widely adopted eClinical platforms in the world, streamlining trials across more than 80 countries and empowering thousands of research teams to work smarter and faster. He serves as an active Board Member of ACDM (Association for Clinical Data Management). reflecting a deep commitment to advancing data integrity and operational excellence across clinical research. With over three decades of experience, Sverre is also an active angel investor, backing more than 30 life science ventures across Europe.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Our guest today is Artem Adrianov. Mathematician. Strategist. Risk based quality mgt trailblazer. As co-founder and CEO of Cyntegrity, Dr. Artem Andrianov has spent over 25 years transforming clinical trials through data intelligence and risk-based methodologies. With a Ph.D. in Mathematical Modelling and an Executive MBA from Cass Business School, Artem blends scientific rigor with business acumen to make trials safer, smarter, and more efficient. Since launching Cyntegrity in 2013, he has led the development of platforms that optimize trial oversight, reduce monitoring costs, and elevate data quality. His work spans collaborations with big Pharma, and his expertise covers Spirometry, ECG, Oncology, ePROs, and centralized monitoring. A speaker and educator, Artem has presented at numerous global conferences, and co-authored the definitive guide to RBQM for clinical researchers. His company’s training arm, MyRBQM Academy, has educated over 1500 professionals from 400+ organizations, setting the standard for RBQM implementation worldwide. Whether modelling risk or mentoring the next generation of trial leaders, Artem is reshaping how the industry thinks about quality, reliability, and patient safety.